Publications (2019)

Publication (International Journal)

1. Matsuyama S, Nao N, Shirato K, Kawase M, Saito S, Takayama I, Nagata N, Sekizuka T, Katoh H, Kato F, Sakata M, Tahara M, Kutsuna S, Ohmagari N, Kuroda M, Suzuki T, Kageyama T, Takeda M.
   Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells.
   Proceedings of the National Academy of Sciences of the United States of America, 117(13), Mar, 2020.
2. Akasaka H, Yamamoto K, Rakugi H, Nagasawa M, Nakamaru R, Ichijo T, Takeda Y, Kurihara I, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Kamemura K, Yoshimoto T, Matsuda Y, Fujita M, Kobayashi H, Watanabe M, Tamura K, Okamura S, Miyauchi S, Izawa S, Chiba Y, Tanabe A, Naruse M. Japan Primary Aldosteronism Study Group, Sex Difference in the Association Between Subtype Distribution and Age at Diagnosis in Patients With Primary Aldosteronism. Hypertension, 74(2), Aug, 2019.
3. Akazawa T, Kusama Y, Fukuda H, Hayakawa K, Kutsuna S, Moriyama Y, Ohashi H, Tamura S, Yamamoto K, Hara R, Shigeno A, Ota M, Ishikane M, Tokita S, Terakado H, Ohmagari N.
   Eight-Year Experience of Antimicrobial Stewardship Program and the Trend of Carbapenem Use at a Tertiary Acute-Care Hospital in Japan-The Impact of Postprescription Review and Feedback.
   Open Forum Infect Disease, 6(10), Sep 2019.
4. Nakatochi M, Kanai M, Nakayama A, Hishida A, Kawamura Y, Ichihara S, Akiyama M, Ikezaki H, Furusyo N, Shimizu S, Yamamoto K, Hirata M, Okada R, Kawai S, Kawaguchi M, Nishida Y, Shimanoe C, Ibusuki R, Takezaki T, Nakajima M, Takao M, Ozaki E, Matsui D, Nishiyama T, Suzuki S, Takashima N, Kita Y, Endoh K, Kuriki K, Uemura H, Arisawa K, Oze I, Matsuo K, Nakamura Y, Mikami H, Tamura T, Nakashima H, Nakamura T, Kato N, Matsuda K, Murakami Y, Matsubara T, Naito M, Kubo M, Kamatani Y, Shinomiya N, Yokota M, Wakai K, Okada Y, Matsuo H.
   Genome-wide meta-analysis identifies multiple novel loci associated with serum uric acid levels in Japanese individuals.
   Communication Biology, 2, Apr, 2019.
5. Kubota H, Suzuki Y, Okuno R, Uchitani Y, Ariyoshi T, Takemura N, Mihara F, Mezaki K, Ohmagari N, Matsui M, Suzuki S, Sekizuka T, Kuroda M, Yokoyama K, Sadamasu K.
   IMP-68, a Novel IMP-Type Metallo-β-Lactamase in Imipenem-Susceptible Klebsiella pneumoniae.
   mSphere, 4(5), Oct, 2019.
6. Yamamoto K, Ujiie M, Noguchi A, Kato Y, Fujiya Y, Mawatari M, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Inoue S, Morikawa S, Ohmagari N.
   Rabies post-exposure prophylactic vaccination for returning travelers to Japan.
   Journal of Infection and Chemotherapy (JIC), 25(12), Dec, 2019.
7. Ngo CQ, Manabe T, Vu GV, Chu HT, Vu TTT, Tran TT, Doan LTP, Takasaki J, Kudo K.
   Difficulties in tuberculosis infection control in a general hospital of Vietnam: a knowledge, attitude, and practice survey and screening for latent tuberculosis infection among health professionals.
   BMC Infectious Diseases, 19(1), Nov, 2019.
8. Tamehiro N, Nishida K, Sugita Y, Hayakawa K, Oda H, Nitta T, Nakano M, Nishioka A, Yanobu-Takanashi R, Goto M, Okamura T, Adachi R, Kondo K, Morita A, Suzuki H.
   Ras homolog gene family H (RhoH) deficiency induces psoriasis-like chronic dermatitis by promoting TH17 cell polarization.
   Journal of Allergy and Clinical Immunology, 143(5), May, 2019.
9. Uda K, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I.
   Targets for Optimizing Oral Antibiotic Prescriptions for Pediatric Outpatients in Japan.
   Japanese Journal of Infectious Diseases (JJID), 72(3), May, 2019.
10. Kusama Y, Ishikane M, Tanaka C, Kimura Y, Yumura E, Hayakawa K, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
    Regional Variation of Antimicrobial Use in Japan from 2013-2016, as Estimated by the Sales Data.
    Japanese Journal of Infectious Diseases (JJID), 72(5), Sep, 2019.
11. Kimura Y, Fukuda H, Hayakawa K, Ide S, Ota M, Saito S, Ishikane M, Kusama Y, Matsunaga N, Ohmagari N.
    Longitudinal trends of and factors associated with inappropriate antibiotic prescribing for non-bacterial acute respiratory tract infection in Japan: A retrospective claims database study, 2012-2017.
    PLoS One, 14(10), Oct, 2019.
12. Niikura R, Nagata N, Yamada A, Honda T, Hasatani K, Ishii N, Shiratori Y, Doyama H, Nishida T, Sumiyoshi T, Fujita T, Kiyotoki S, Yada T, Yamamoto K, Shinozaki T, Takata M, Mikami T, Mabe K, Hara K, Fujishiro M, Koike K.
    Efficacy and Safety of Early vs Elective Colonoscopy for Acute Lower Gastrointestinal Bleeding.
    Gastroenterology, 158(1), Jan, 2020.
13. Moriyama Y, Ishikane M, Hayakawa K, Yamamoto K, Akazawa T, Sugiki Y, Ohmagari N.
    Comparison of knowledge to antimicrobial stewardship institution policies targeting Staphylococcus aureus bacteremia and candidemia between medical doctors and pharmacists in an academic teaching hospital in Japan.
    Journal of Infection and Chemotherapy (JIC), 25(5), May, 2019.
14. Akiyama Y, Maeda D, Katoh H, Morikawa T, Niimi A, Nomiya A, Sato Y, Kawai T, Goto A, Fujimura T, Fukuhara H, Nakagawa T, Igawa Y, Ishikawa S, Fukayama M, Kume H, Homma Y.
    Molecular Taxonomy of Interstitial Cystitis/Bladder Pain Syndrome Based on Whole Transcriptome Profiling by Next-Generation RNA Sequencing of Bladder Mucosal Biopsies.
    Journal of Urology, 202(2), Aug, 2019.
15. Ishikane M, Arima Y, Itoda I, Yamagishi T, Takahashi T, Matsui T, Sunagawa T, Ohnishi M, Oishi K.
    Case-control study of risk factors for incident syphilis infection among men who have sex with men in Tokyo, Japan.
    Western Pacific Surveillance and Response Journal (WPSAR), 10(4), Dec, 2019.
16. Otsuka-Ono H, Hori N, Ohta H, Uemura Y, Kamibeppu K.
    A childhood immunization education program for parents delivered during late pregnancy and one-month postpartum: a randomized controlled trial.
    BMC Health Services Research, 19(1), Nov, 2019.
17. Inagaki A, Moriyama Y, Morioka S, Wakimoto Y, Shida Y, Ohmagari N.
    A case of Klebsiella pneumoniae spondylitis and bacteremia potentially due to inflammation around a fecalith.
    Journal of Infection and Chemotherapy (JIC), 25(6), Jun, 2019.
18. Takaya S, Kato Y, Katanami Y, Yamamoto K, Kutsuna S, Takeshita N, Hayakawa K, Kanagawa S, Komaki-Yasuda K, Kano S, Ohmagari N.
    Imported Malaria at a Referral Hospital in Tokyo from 2005 to 2016: Clinical Experience and Challenges in a Non-Endemic Setting.
    American Journal of Tropical Medicine and Hygiene, 100(4), Apr, 2019.
19. Sherchan JB, Tada T, Shrestha S, Uchida H, Hishinuma T, Morioka S, Shahi RK, Bhandari S, Twi RT, Kirikae T, Sherchand JB.
    Emergence of clinical isolates of highly carbapenem-resistant Klebsiella pneumoniae co-harboring bla (NDM-5) and bla (OXA-181 or -232) in Nepal.
    International Journal of Infectious Diseases (IJID), 92, Mar, 2020.
20. Manabe T, Takasaki J, Kudo K.
    Seasonality of newly notified pulmonary tuberculosis in Japan, 2007-2015.
    BMC Infectious Diseases, 19(1), Jun, 2019
21. Ishii S, Muraki Y, Kusama Y, Yagi T, Goto R, Ebisui A, Kawabe A, Inose R, Ohmagari N.
    The Trend for Antibiotic Use for Clostridioides (Clostridium) difficile Infection in Japan.
    Biological and Pharmaceutical Bulletin, 43(4), 2020.
22. Kusama Y, Ishikane M, Tanaka C, Tsuzuki S, Muraki Y, Ohmagari N.
    What is the impact of the change in DDD of amoxicillin and amoxicillin combined with β-lactamase inhibitors on nationwide surveillance of antimicrobial use?.
    Journal of Antimicrobial Chemotherapy, 74(10), Oct, 2019.
23. Ujiie M.
    Rubella Resurgence in Japan 2018-2019.
    J Travel Med, 26(6), Sep, 2019.
24. Ishikane M, Kusama Y, Tanaka C, Hayakawa K, Kuwahara T, Ohmagari N.
    Epidemiology of antimicrobial use among nursing homes in Japan, 2016: A pilot study.
    Japanese Journal of Infectious Diseases (JJID), Jan, 2020.
25. Hayakawa K, Nakano R, Hase R, Shimatani M, Kato H, Hasumi J, Doi A, Sekiya N, Nei T, Okinaka K, Kasahara K, Kurai H, Nagashima M, Miyoshi-Akiyama T, Kakuta R, Yano H, Ohmagari N.
    Comparison between IMP carbapenemase-producing Enterobacteriaceae and non-carbapenemase-producing Enterobacteriaceae: a multicentre prospective study of the clinical and molecular epidemiology of carbapenem-resistant Enterobacteriacea.
    Journal of Antimicrobial Chemother, 75(3), Mar, 2020.
26. Tachino J, Yamamoto K, Shimizu K, Shintani A, Kimura A, Ogura H, Shimazu T.
    Quick risk assessment profile (qRAP) is a prediction model for post-traumatic venous thromboembolism.
    Injury, 50(9), Sep, 2019.
27. Tsuzuki S, Fujitsuka N, Horiuchi K, Ijichi S, Gu Y, Fujitomo Y, Takahashi R, Ohmagari N.
    Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population.
    Scientific Reports, 10(1), Feb, 2020.
28. Tsuzuki S, Baguelin M, Pebody R, van Leeuwen E.
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine, 38(4), Jan, 2020.
29. Saiki A, Otsuki M, Mukai K, Hayashi R, Shimomura I, Kurihara I, Ichijo T, Takeda Y, Katabami T, Tsuiki M, Wada N, Ogawa Y, Kawashima J, Sone M, Inagaki N, Yoshimoto T, Okamoto R, Takahashi K, Kobayashi H, Tamura K, Kamemura K, Yamamoto K, Izawa S, Kakutani M, Yamada M, Tanabe A, Naruse M.
    Basal Plasma Aldosterone Concentration Predicts Therapeutic Outcomes in Primary Aldosteronism.
    Journal of the Endocrine Society, 4(4), Feb, 2020.
30. Gu Y, Fujitomo Y, Soeda H, Nakahama C, Hasegawa N, Maesaki S, Maeda M, Matsumoto T, Miyairi I, Ohmagari N.
    A nationwide questionnaire survey of clinic doctors on antimicrobial stewardship in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(2), Feb, 2020.
31. Matsui T, Kinoshita N, Maeki T, Kutsuna S, Nakamura K, Nakamoto T, Ishikane M, Tajima S, Kato F, Taniguchi S, Lim CK, Saijo M, Ohmagari N.
    Dengue Virus Type 2 Infection in a Traveler Returning from Saudi Arabia to Japan.
    Japanese Journal of Infectious Diseases (JJID). 2019, Sep, 72(5).
32. Matsui T, Nakamoto T, Hayakawa K, Yamamoto K, Nakamura K, Kutsuna S, Nagashima M, Toriniwa H, Komiya T, Ohmagari N.
    Case Report: Two Cases of Acute Q Fever from the Same Family Who Returned from Malawi to Japan.
    American Journal of Tropical Medicine and Hygiene, 101(6), Dec, 2019.
33. Mashima I, Miyoshi-Akiyama T, Tomida J, Kutsuna R, Washio J, Takahashi N, Nakazawa F, Sato T, Kawamura Y.
    Draft Genome Sequences of Two Veillonella tobetsuensis Clinical Isolates from Intraoperative Bronchial Fluids of Elderly Patients with Pulmonary Carcinoma.
    Microbiology Resource Announcements, 8(38), Sep, 2019.
34. Kusama Y, Muraki Y, Mochizuki T, Kurai H, Gu Y, Ohmagari N.
    Relationship between drug formulary and frequently used cephalosporins, macrolides and quinolones in Japanese hospitals.
    Journal of Infection and Chemotherapy (JIC), 26(2), Feb, 2020.
35. Morioka S, Tajima T, Sugiki Y, Hayakawa K, Ohmagari N.
    Adherence to personal protective equipment use among nurses in Japanese tertiary care hospitals: what determines variability?.
    Journal of Hospital Infection, 104(3), Mar, 2020.
36. Morioka S, Hashikura K, Nishio H, Ohmagari N.
    Anterior Tibial Artery Hemorrhaging Mimicking Necrotizing Fasciitis.
    Internal Medicine Journal, 58(20), Oct, 2019.
37. Tamura S, Hayakawa K, Miyoshi-Akiyama T, Nakanishi M, Yano T, Shimoya K, Sugiki Y, Mezaki K, Ohmagari N.
    Isolation of OXA-181 Carbapenemase-Producing Escherichia coli and OXA-232 Carbapenemase-Producing Klebsiella pneumoniae from a Pregnant Woman Returning to Japan from India.
    Japanese Journal of Infectious Diseases (JJID), 72(4), Jul, 2019.
38. Kakuwa T, Ariga A, Takasaki J, Kato M, Igari T, Shida Y, Okafuji T, Nakamura S, Miyazaki Y, Katano H, Iikura M, Izumi S, Sugiyama H.
    Mucor pulmonary embolism in a patient with myelodysplastic syndrome.
    Respiratory Medicine Case Reports, 30, Mar, 2020.
39. Ujihara T, Yamamoto K, Kitaura T, Katanami Y, Kutsuna S, Takeshita N, Hayakawa K, Ohmagari N.
    Calcium Pyrophosphate Deposition Disease Involving a Lumbar Facet Joint Following Urinary Tract Infection.
    Internal Medicine Journal, 58(12), Jun, 2019.
40. Suzuki T, Takaya S, Kunimatsu J, Kutsuna S, Hayakawa K, Shibata H, Yasumi T, Ohmagari N.
    GATA2 mutation underlies hemophagocytic lymphohistiocytosis in an adult with primary cytomegalovirus infection.
    Journal of Infection and Chemotherapy (JIC), 26(2), Feb, 2020.
41. Diaz-Menendez M, Esteban ET, Ujiie M, Calleri G, Rothe C, Malvy D, Nicastri E, Bissinger AL, Grandadam M, Alpern JD, Gobbi F, Schlagenhauf P, Duvignaud A, Javelle E, Nakamoto T, Antinori S, Hamer DH.
    Travel-associated chikungunya acquired in Myanmar in 2019.
    Euro Surveillance, 25(1), Jan, 2020.
42. Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.
    Meningoencephalitis Caused by a Campylobacter fetus in a Patient with Chronic Alcoholism.
    Internal Medicine Journal, 58(15), Aug, 2019.
43. Ujiie M, Terada M, Kobayakawa M, Ohmagari N.
    Clinical trial with unlicensed yellow fever vaccine in Japan.
    Journal of Travel Medicine, 26(6), Sep, 2019.
44. Higashino T, Morimoto K, Nakaoka H, Toyoda Y, Kawamura Y, Shimizu S, Nakamura T, Hosomichi K, Nakayama A, Ooyama K, Ooyama H, Shimizu T, Ueno M, Ito T, Tamura T, Naito M, Nakashima H, Kawaguchi M, Takao M, Kawai Y, Osada N, Ichida K, Yamamoto K, Suzuki H, Shinomiya N, Inoue I, Takada T, Matsuo H.
    Dysfunctional missense variant of OAT10/SLC22A13 decreases gout risk and serum uric acid levels.
    Annals of the Rheumatic Diseases (ARD), 79(1), Jan, 2020.
45. Takaya S, Kutsuna S, Kato Y, Ohmagari N.
    The Authors' Reply to "Both Macro and Micro Filarial Treatment May Be Necessary to Treat Hydrocele Due to a Wuchereria bancrofti Infection.
    Internal Medicine, 58(16), Aug, 2019.
46. Tanabe S, Kutsuna S, Tsuboi M, Takeshita N, Hayakawa K, Ohmagari N.
    Reply to "Initial Narrow- or Broad-spectrum Treatment for Meningoencephalitis".
    Internal Medicine, 59(3), Feb, 2020.
47. Yamamoto K, Yanagawa Y, Oka S, Watanabe K.
    Two cases of endoscopically diagnosed amebic colitis treated with paromomycin monotherapyPLoS Neglected Tropical Diseases, 14(3), Mar, 2020.
48. Kizaki M, Takahashi N, Iriyama N, Okamoto S, Ono T, Usui N, Inokuchi K, Nakaseko C, Kurokawa M, Sumi M, Nakamura F, Kawaguchi T, Suzuki R, Yamamoto K, Ohnishi K, Matsumura I, Naoe T; New TARGET investigators.
    Efficacy and safety of tyrosine kinase inhibitors for newly diagnosed chronic-phase chronic myeloid leukemia over a 5-year period: results from the Japanese registry obtained by the New TARGET system.
    International Journal of Hematology (IJH), 109(4), Apr, 2019.
49. Uda K, Okubo Y, Kinoshita N, Morisaki N, Kasai M, Horikoshi Y, Miyairi I.
    Nationwide survey of indications for oral antimicrobial prescription for pediatric patients from 2013 to 2016 in Japan.
    Journal of Infection and Chemotherapy (JIC), 25(10), Oct, 2019.
50. Mori A, Hatano T, Inoshita T, Shiba-Fukushima K, Koinuma T, Meng H, Kubo SI, Spratt S, Cui C, Yamashita C, Miki Y, Yamamoto K, Hirabayashi T, Murakami M, Takahashi Y, Shindou H, Nonaka T, Hasegawa M, Okuzumi A, Imai Y, Hattori N.
    Parkinson's disease-associated iPLA2-VIA/PLA2G6 regulates neuronal functions and α-synuclein stability through membrane remodeling.
    Proceedings of the National Academy of Sciences of the United States of America, 116(41), Oct, 2019.
51. Jinnin M, Ohta A, Ishihara S, Amano H, Atsumi T, Fujimoto M, Kanda T, Kawaguchi Y, Kawakami A, Mimori A, Mimori T, Mimura T, Muro Y, Sano H, Shimizu J, Takeuchi T, Tanaka Y, Yamamoto K, Sumida T, Kohsaka H; Research Team for Autoimmune Diseases, The Research Program for Intractable Disease of the Ministry of Health, Labor and Welfare.
    First external validation of sensitivity and specificity of the European League Against Rheumatism (EULAR)/American College of Rheumatology (ACR) classification criteria for idiopathic inflammatory myopathies with a Japanese cohort.
    Annals of the Rheumatic Diseases (ARD), 79(3), Mar, 2020.
52. Harada S, Aoki K, Yamamoto S, Ishii Y, Sekiya N, Kurai H, Furukawa K, Doi A, Tochitani K, Kubo K, Yamaguchi Y, Narita M, Kamiyama S, Suzuki J, Fukuchi T, Gu Y, Okinaka K, Shiiki S, Hayakawa K, Tachikawa N, Kasahara K, Nakamura T, Yokota K, Komatsu M, Takamiya M, Tateda K, Doi Y.
    Clinical and Molecular Characteristics of Klebsiella pneumoniae Isolates Causing Bloodstream Infections in Japan: Occurrence of Hypervirulent Infections in Health Care.
    Journal of Clinical Microbiology, 57(11), Oct, 2019.
53. Yanagihara K, Matsumoto T, Aoki N, Sato J, Wakamura T, Kiyota H, Tateda K, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Akiba Y, Masunaga S, Takeuchi K, Takeda H, Miki M, Kumagai T, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Ishigaki S, Kobayasi N, Takasaki J, Mezaki K, Iwata S, Katouno Y, Inose R, Niki Y, Kawana A, Fujikura Y, Kudo M, Hirano T, Yamamoto M, Miyazawa N, Tsukada H, Aso S, Yamamoto Y, Iinuma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Kawabata A, Sugaki Y, Seki M, Hamaguchi S, Toyokawa M, Kakeya H, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Hayasi M, Mikasa K, Kasahara K, Koizumi A, Korohasi N, Matumoto T, Yosimura Y, Katanami Y, Takesue Y, Wada Y, Sugimoto K, Yamamoto T, Kuwabara M, Doi M, Simizu S, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Yatera K, Fujita M, Kadota J, Hiramatsu K, Aoki Y, Magarifuchi H, Oho M, Morinaga Y, Suga M, Muranaka H, Fujita J, Higa F, Tateyama M.
    Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for clinical microbiology in 2014: General view of the pathogens' antibacterial susceptibility.
    Journal of Infection and Chemotherapy (JIC), 25(9), Sep, 2019.
54. Moriyama Y, Ishikane M, Mezaki K, Ohmagari N.
    Comparison of penicillins (penicillin G and ampicillin) and cefazolin as a definitive therapy against penicillin-susceptible Staphylococcus aureus (PSSA) bacteremia in Japan: a retrospective cohort study.
    Journal of Infection and Chemotherapy (JIC), 26(4), Dec, 2019.
55. Tsuzuki S, Matsunaga N, Yahara K, Gu Y, Hayakawa K, Hirabayashi A, Kajihara T, Sugai M, Shibayama K, Ohmagari N.
    National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(4), Dec, 2019.
56. Kinoshita N, Komura M, Tsuzuki S, Shoji K, Miyairi I.
    The effect of preauthorization and prospective audit and feedback system on oral antimicrobial prescription for outpatients at a children's hospital in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(6), Feb, 2020.
57. Takaya S, Hayakawa K, Matsunaga N, Moriyama Y, Katanami Y, Tajima T, Tanaka C, Kimura Y, Saito S, Kusama Y, Morioka S, Fujitomo Y, Ohmagari N.
    Surveillance systems for healthcare-associated infection in high and upper-middle income countries: A scoping review.
    Journal of Infection and Chemotherapy (JIC), 26(5), Feb, 2020.
58. Maeda M, Muraki Y, Anno Y, Sawa A, Kusama Y, Ishikane M, Ohmagari N, Ohge H.
    Development of the predicted and standardized carbapenem usage metric: Analysis of the Japanese Diagnosis Procedure Combination payment system data.
    Journal of Infection and Chemotherapy (JIC), 26(6), Mar, 2020.
59. Tsuzuki S, Fujitsuka N, Horiuchi K, Ijichi S, Gu Y, Fujitomo Y, Takahashi R, Ohmagari N.
    Factors associated with sufficient knowledge of antibiotics and antimicrobial resistance in the Japanese general population.
    Scientific Reports, 10(1), Feb, 2020.
60. Tsuzuki S, Baguelin M, Pebody R, van Leeuwen E.
    Modelling the optimal target age group for seasonal influenza vaccination in Japan.
    Vaccine, 38(4), Jan, 2020.
61. Tsuzuki S, Kimura Y, Ishikane M, Kusama Y, Ohmagari N.
    Cost of inappropriate antimicrobial use for upper respiratory infection in Japan.
    BMC Health Services Research, 20(1), Feb, 2020.
62. Tsuzuki S, Matsunaga N, Yahara K, Gu Y, Hayakawa K, Hirabayashi A, Kajihara T, Sugai M, Shibayama K, Ohmagari N.
    National trend of blood-stream infection attributable deaths caused by Staphylococcus aureus and Escherichia coli in Japan.
    Journal of Infection and Chemotherapy (JIC), 26(4), Dec, 2019.
63. Kanamori K, Shoji K, Kinoshita N, Ishiguro A, Miyairi I.
    Complications of Herpes Zoster in Children.
    Pediatrics International, 61(12), Dec, 2019.
64. Tao C, Kinoshita N, Shoji K, Motooka D, Nakamura S, Eura R, Ueoka K, Kubota M, Ishiguro A, Miyairi I.
    Urinary tract infection due to anaerobic bacteria in a two-month-old infant.
    Journal of Infection and Chemotherapy (JIC), 25(5), May, 2019.
65. Yamamoto K.
    Oral Manifestation Like Forchheimer Spots of Dengue Fever.
    American Journal of Tropical Medicine and Hygiene, 101(4), Oct, 2019.
66. Akashi H, Ishizuka A, Lee S, Irie M, Oketani H, Akashi R.
    The role of the G20 economies in global health.
    Global Health & Medicine, 1(1), Nov, 2019.

Presentations at International Conferences and Forums

1. Tsuzuki S.
   The Characteristics of Influenza-Like Illness Management in Japan.
   IDWEEK 2019, Washington D.C., US, October 2019.
2. Tsuzuki S, Kimura Y, Ishikane M, Kusama Y, Ohmagari N.
   Cost of Antimicrobial Use for Upper Respiratory Infection in Japan.
   IDWEEK 2019, Washington D.C., US, October 2019.
3. Yamamoto K.
   Which Type of Varicella-Zoster Virus Infection is at High Risk for Airborne Transmissions?.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
4. Yamamoto K.
   Catch-up Measles, Mumps, Rubella, and Varicella Immunization on Pretravel Consultation in Japan.
   CISTM, Washington D.C., US, June, 2019.
5. Gu Y, Fujitomo Y, Takahashi R, Ohmagari N.
   Effect of Media Strategy for Public Awareness-raising Activities on Antimicrobial Resistance in Japan.
   The 5th International Conference on Prevention and Infection Control. Geneva, Switzerland, September, 2019.
6. Gu Y.
   Country deep dive on Japan: High to middle income AMR strategies.
   Antimicrobial Resistance Summit.  Singapore, Singapore, October, 2019.
7. Nomoto H, Ishikane M, Ohmagari N.
   Clinical characteristics of adult rubella observed during an outbreak in Japan in 2018.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
8. Kusama Y, Ishikane M, Tanaka C, Kimura Y, Yamasaki D, Tanabe M, Murai Y, Ohmagari N.
   Aminoglycoside injections are the most frequently prescribed to children in outpatient settings: nation-wide population-based study in Japan in 2016.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
9. Kusama Y, Ishikane M, Fukuda M, Yumura E, Tanaka C, Kimura Y, Hayakawa K, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
   Decreasing of national antibiotic consumption and economic impact during 2013-2017 in Japan.
   29th European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), Amsterdam, Netherlands, April, 2019.
10. Ishikane M, Tanaka C, Ono S, Kusama Y, Tsuzuki S, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
    First National Survey of Antibiotic Use Prescribed by All Dentists in Japan from 2015 to 2017 using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
11. Kusama Y, Ishikane M, Kihara T, Ohmagari N.
    Cephalosporins and Quinolones Account for Ninety-five Percent of Oral Antibiotic Treatment for Uncomplicated Cystitis in Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
12. Yamasaki D, Kusama Y, Ishikane M.
    Age-specific Distribution of Antimicrobial days of therapy (DOT) using National Database of Health Insurance Claims and Specific Health Checkups of Japan (NDB Japan) - Comparison with defined daily doses per 1000 inhabitants per day (DID).
    IDWEEK 2019, Washington D.C., US, October 2019.
13. Ishikane M, Tanaka C, Kusama Y, Tsuzuki S, Muraki Y, Yamasaki D, Tanabe M, Ohmagari N.
    Comparison of Patterns of National Oral Antibiotic Use between All Dentists and Medical Doctors in Japan in 2016 using the National Database of Health Insurance Claims and Specific Health Checkups of Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
14. Moriyama Y, Ishikane M, Kusama Y, Matsunaga N, Tajima T, Hayakawa K, Ohmagari N.
    First National Survey of Antimicrobial and Antifungal Stewardship in Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
15. Ishikane M.
    Controlling MDROs Through Stewardship in Asia: Initiatives in Japan.
    IDWEEK 2019, Washington D.C., US, October 2019.
16. Matsunaga N.
    The incidence and antimicrobial prescription patterns of upper urinary tract infection in Japan.
    ECCMID2019, Amsterdam, Netherlands, April 2019.
17. Morioka S.
    Antibiotic Therapy for Hospital Acquired Pneumonia.
    APHC2019, Surabaya, Indonesia, August 2019.
18. Morioka S.
    Sepsis in patients with weeks of life expectancy.
    APHC2019, Surabaya Indonesia, August 2019.
19. Fujitomo Y, Yamamoto S, Gu Y, Takahashi R, Ohmagari N.
    Clinician-targeted refresher courses for the management of RTIs are effective in improving physicians’ skills for the management of acute RTIs and for promoting appropriate use of antibiotics in outpatient care.
    ICPIC 2019, Geneva, Switzerland, September 2019.